Protocol Ledger

NCT04379570 · Phase III · ACTIVE NOT RECRUITING

Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy

Interventional Phase III clinical trial protocol NCT04379570 sponsored by Alliance for Clinical Trials in Oncology in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-02-15 Enrollment: 1,167 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04379570
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,167 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04379570
Protocol FieldVerified Registry Value
NCT IdentifierNCT04379570
Consolidated Lead SponsorAlliance for Clinical Trials in Oncology
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment1,167 participants (ACTUAL)
Registered Start Date2021-02-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04379570
Hospital Research SiteLocationSite Profile
University of Alabama at Birmingham Cancer CenterBirmingham, ALOpen Hospital Dossier ->
Fairbanks Memorial HospitalFairbanks, AKOpen Hospital Dossier ->
Cancer Center at Saint Joseph'sPhoenix, AZOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI